We guide BioPharma companies through developing expanded access strategies up to full EAP execution and preparation for full commercial launch. We have experience in a wide range of expanded access use cases, across different regions and therapeutics areas:
Conducting expanded access programs on behalf of our clients is our core expertise. Our team of experts handles areas such as Regulatory, Quality, Site Management, Supply Chain, Real-World Data, and Pharmacovigilance.
myTomorrows Team
6 Mar 2025
11 mins read
myTomorrows Team
25 Feb 2025
10 mins read
myTomorrows Team
25 Feb 2025
5 mins read
myTomorrows Team
17 Feb 2025
5 mins read
myTomorrows Team
11 Feb 2025
11 mins read
Danny den Hamer
6 Feb 2025
6 mins read
Romina Dibra
14 Jan 2025
7 mins read
myTomorrows Team
17 Dec 2024
4 mins read
myTomorrows Team
12 Dec 2024
9 mins read
myTomorrows Team
22 Nov 2024
4 mins read